Frontlight ResearchEarly access
Trial site
Yokohama City Minato Red Cross Hospital
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease4 trials
- Atrial fibrillation3 trials
- Atopic dermatitis (eczema)1 trial
- Lupus (SLE)1 trial
- Mild cognitive impairment1 trial
- Peripheral artery disease1 trial
- Schizophrenia1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting3 trials
- Lead sponsor
- Boston Scientific Corporation2 trials
- Eli Lilly and Company2 trials
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
- Amgen1 trial
- Biogen1 trial
- and 2 more
Running trials
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia
Recruiting
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- Peripheral artery disease1 recruiting
- Schizophrenia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 19 Nov 2026